In our comprehensive review, we outline the molecular biology of HER2 in NSCLC, including distinctions between HER2 mutations, amplification, and overexpression, and we delve into the diverse diagnostic complexities. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.